Cargando…

CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is one of the common metabolic diseases characterized by hepatic lipid accumulation. Insulin resistance and microcirculation dysfunction are strongly associated with NAFLD. CX08005, an inhibitor of PTP1B with the IC(50) of 0.75 ± 0.07 μM, has been proven to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiang, Zhang, Xiaolin, Tian, Jinying, Li, Juan, Li, Xuechen, Wu, Song, Liu, Yuying, Han, Jingyan, Ye, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863901/ https://www.ncbi.nlm.nih.gov/pubmed/36678603 http://dx.doi.org/10.3390/ph16010106

Ejemplares similares

Draft Genome Sequence of Aeromonas sobria Strain 08005, Isolated from Sick Rana catesbeiana
por: Yang, Qiu-Hua, et al.
Publicado: (2017)

Cx43 Promotes Endothelial Cell Migration and Angiogenesis via the Tyrosine Phosphatase SHP-2
por: Mannell, Hanna, et al.
Publicado: (2021)

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease
por: Rao, Shenzong, et al.
Publicado: (2019)

A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis
por: Ai, Luoyan, et al.
Publicado: (2015)

Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation
por: Gu, Juanjuan, et al.
Publicado: (2016)

Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models
por: Yi, Qin, et al.
Publicado: (2018)

Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
por: Özcabı, Bahar, et al.
Publicado: (2019)

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
por: Lee, Jibeom, et al.
Publicado: (2023)

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
por: Fang, Miao, et al.
Publicado: (2020)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model
por: Xu, Ren-ying, et al.
Publicado: (2012)

Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver
por: Moya, Marta, et al.
Publicado: (2012)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2015)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43)
por: Liu, YiHao, et al.
Publicado: (2022)

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
por: Nakamura, Yoshiko, et al.
Publicado: (2019)

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
por: Ke, Zunli, et al.
Publicado: (2023)

Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria
por: Chen, Liting, et al.
Publicado: (2022)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
por: Hsu, Ming-Fo, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy
por: Wang, Liyang, et al.
Publicado: (2020)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better
por: Lee, Tae-Rin, et al.
Publicado: (2013)

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
por: Xu, Xin, et al.
Publicado: (2015)

Attenuated Microcirculation in Small Metastatic Tumors in Murine Liver
por: Ziemys, Arturas, et al.
Publicado: (2021)

T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis
por: Fukushima, Atsushi, et al.
Publicado: (2010)

Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer
por: Wang, Tao, et al.
Publicado: (2022)

Mutations of CX46/CX50 and Cataract Development
por: Shi, Yumeng, et al.
Publicado: (2022)

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Protein tyrosine phosphatases in glioma biology
por: Navis, Anna C., et al.
Publicado: (2009)

Metabolic regulation by protein tyrosine phosphatases
por: Knobler, Hilla, et al.
Publicado: (2014)

Role of Protein Tyrosine Phosphatases in Plants
por: Shankar, Alka, et al.
Publicado: (2015)

Crystal structure of the Yersinia tyrosine phosphatase
por: Bliska, James B.
Publicado: (1995)

T Cell Protein Tyrosine Phosphatase in Osteoimmunology
por: Wang, Ya-nan, et al.
Publicado: (2021)

Protein tyrosine phosphatases in cell adhesion
por: Young, Katherine A., et al.
Publicado: (2021)

Protein Tyrosine Phosphatases: Mechanisms in Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Xia, Jinying, et al.
Publicado: (2022)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s06uvorvglaec5s8c6vren8882